VIDEO: Virtual platforms may boost enrollment, encourage diversity in clinical trials

In this video exclusive, Aasma Shaukat, MD, MPH, professor at NYU Grossman School of Medicine, discusses how her group achieved diverse enrollment for PREEMPT CRC, a study designed to validate a blood test for colorectal cancer screening.“In this trial, we were able to enroll a much higher proportion of both Blacks and Hispanics than traditionally in clinical trials and also much higher than representation in the U.S. population,” Shaukat, who also is co-lead and co-principal investigator for the Prevention of Colorectal Cancer Through Multiomics Blood Testing (PREEMPT CRC) trial,Read More

Generated by Feedzy